Evommune Inc. (EVMN) vs SAB Biotherapeutics, Inc. (SABS)
Evommune Inc. and SAB Biotherapeutics, Inc. are both Biotechnology companies. Evommune Inc. and SAB Biotherapeutics, Inc. are of similar size ($309.9M and $304.8M). Across the 10 metrics below, SAB Biotherapeutics, Inc. leads on 6 and Evommune Inc. on 4.
Valuation
Profitability
| Metric | EVMN | SABS | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (141.99%) | (19.21%) | (57.72%) |
| Return on assets | (62.71%) | (16.24%) | (49.22%) |
| Return on invested capital | (82.46%) | (38.97%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack